Skip to main content
Equibles

PROFUND ADVISORS LLC

Position in TWST — Twist Bioscience Corp

CIK 1129919 BETHESDA, MD
Back to TWST Full portfolio

Position in TWST

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$2,170,253
+$125,040 QoQ
Shares Held
21,095
-51.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#146
of 337 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TWST Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $165,155,882 across 170 Biotechnology names. TWST ranks #7 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 23,398 $11,622,488
2 REGN
Regeneron Pharmaceuticals, Inc.
 10,444 $6,512,251
3 ALNY
Alnylam Pharmaceuticals, Inc.
 13,814 $4,158,428
4 MRNA
Moderna, Inc.
 33,142 $2,320,934
5 APGE
Apogee Therapeutics, Inc.
 17,163 $2,278,044
6 CYTK
Cytokinetics Inc
 25,572 $2,178,478
7 TWST
Twist Bioscience Corp
This page 		21,095 $2,170,253
8 KRYS
Krystal Biotech, Inc.
 5,770 $2,144,535

All Filings in TWST

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,170,253 21,095
2026-03-31 $2,045,213 43,039
2025-12-31 $1,343,500 42,355
2025-09-30 $693,763 24,654
2025-06-30 $593,459 16,131
2025-03-31 $814,762 20,753
2024-12-31 $856,953 18,441
2024-09-30 $1,243,082 27,514
2024-06-30 $958,496 19,450
2024-03-31 $1,311,671 38,230
2023-12-31 $1,386,452 37,614
2023-09-30 $1,151,882 56,855
2023-06-30 $1,526,234 74,596
2023-03-31 $1,198,241 79,459
2022-06-30 $266,465 7,622
2022-03-31 $412,076 8,345
2021-12-31 $648,218 8,376
2021-09-30 $995,783 9,309